Wellington Management Group’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.85M Buy
167,429
+12,000
+8% +$132K ﹤0.01% 1589
2025
Q1
$1.39M Sell
155,429
-43,062
-22% -$385K ﹤0.01% 1632
2024
Q4
$1.87M Buy
198,491
+7,162
+4% +$67.4K ﹤0.01% 1572
2024
Q3
$1.54M Sell
191,329
-159,258
-45% -$1.28M ﹤0.01% 1606
2024
Q2
$2.97M Buy
350,587
+19,625
+6% +$166K ﹤0.01% 1426
2024
Q1
$2.97M Buy
330,962
+43,860
+15% +$393K ﹤0.01% 1445
2023
Q4
$3.23M Buy
287,102
+116,164
+68% +$1.31M ﹤0.01% 1401
2023
Q3
$1.48M Sell
170,938
-11,322
-6% -$97.7K ﹤0.01% 1534
2023
Q2
$1.89M Buy
182,260
+41,999
+30% +$435K ﹤0.01% 1489
2023
Q1
$1.52M Sell
140,261
-3,171
-2% -$34.4K ﹤0.01% 1562
2022
Q4
$1.61M Sell
143,432
-8,078
-5% -$90.6K ﹤0.01% 1547
2022
Q3
$1.54M Buy
151,510
+4,042
+3% +$41K ﹤0.01% 1575
2022
Q2
$1.34M Sell
147,468
-919
-0.6% -$8.33K ﹤0.01% 1618
2022
Q1
$1.42M Sell
148,387
-49,667
-25% -$475K ﹤0.01% 1675
2021
Q4
$2.19M Sell
198,054
-52,165
-21% -$577K ﹤0.01% 1643
2021
Q3
$1.85M Sell
250,219
-8,477,105
-97% -$62.7M ﹤0.01% 1695
2021
Q2
$127M Buy
8,727,324
+1,263,122
+17% +$18.3M 0.02% 568
2021
Q1
$152M Buy
7,464,202
+1,996,902
+37% +$40.8M 0.03% 487
2020
Q4
$97.2M Buy
5,467,300
+739,708
+16% +$13.1M 0.02% 598
2020
Q3
$69.9M Buy
4,727,592
+244,815
+5% +$3.62M 0.01% 606
2020
Q2
$94.1M Buy
4,482,777
+315,254
+8% +$6.62M 0.02% 541
2020
Q1
$96.3M Buy
4,167,523
+989,986
+31% +$22.9M 0.03% 467
2019
Q4
$82.3M Buy
+3,177,537
New +$82.3M 0.02% 615
2016
Q4
Sell
-190,950
Closed -$6.92M 2244
2016
Q3
$6.92M Buy
+190,950
New +$6.92M ﹤0.01% 1285